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Cleavage of histone pre-mRNAs at the 3 end is guided by the U7 snRNP, which is a component of a larger 3-end
processing complex. To identify other components of this complex, we isolated proteins that stably associate with a
fragment of histone pre-mRNA containing all necessary processing elements and a biotin affinity tag at the 5 end.
Among the isolated proteins, we identified three well-characterized processing factors: the stem-loop binding protein
(SLBP), which interacts with the stem-loop structure upstream of the cleavage site, and both Lsm11 and SmB,
which are components of the U7-specifc Sm ring. We also identified 3hExo/Eri-1, a multifunctional 3 exonuclease
that is known to trim the 3 end of 5.8S rRNA. 3hExo primarily binds to the downstream portion of the stem-loop
structure in mature histone mRNA, with the upstream portion being occupied by SLBP. The two proteins bind their
respective RNA sites in a cooperative manner, and 3hExo can recruit SLBP to a mutant stem-loop that itself does
not interact with SLBP. UV-cross-linking studies used to characterize interactions within the processing complex
demonstrated that 3hExo also interacts in a U7-dependent manner with unprocessed histone pre-mRNA. However,
this interaction is not required for the cleavage reaction. The region between the cleavage site and the U7-binding
site interacts with three low-molecular-weight proteins, which were identified as components of the U7-specific Sm
core: SmB, SmD3, and Lsm10. These proteins likely rigidify the substrate and function as the molecular ruler in
determining the site of cleavage.
Replication-dependent histone pre-mRNAs are processed
at the 3 end by a single endonucleolytic cleavage that requires
the U7 snRNP (12). Cleavage occurs between two sequence
elements that are separated by approximately 15 nucleotides: a
highly conserved stem-loop (SL) structure and a purine-rich
histone downstream element (HDE). The resultant histone
mRNA ends with the SL, followed by a 5-nucleotide single-
stranded tail. The HDE interacts with the U7 snRNP, which is
composed of an approximately 60-nucleotide U7 snRNA and
an Sm ring. The Sm ring of the U7 snRNP differs from that
found in spliceosomal snRNPs, as it contains Lsm10 and
Lsm11 proteins in place of the SmD1 and SmD2 proteins. The
remaining five components of the ring (SmB, SmD3, SmE,
SmF, and SmG) are common to both types of snRNPs (31, 32).
The U7 snRNP is recruited to histone pre-mRNA primarily
through formation of a double-stranded RNA between the 5
end of U7 snRNA and the HDE. The SL structure forms a
tight complex with the SL binding protein (SLBP). SLBP also
binds a 100-kDa zinc finger protein (ZFP100) that in turn
interacts with Lsm11 and hence may additionally stabilize U7
snRNP on the HDE (12).
The cleavage reaction is catalyzed by CPSF-73 (14), a mem-
ber of the metallo--lactamase family of mostly hydrolytic en-
zymes that utilize zinc ions during catalysis (2, 6). Following
the initial endonucleolytic cleavage, CPSF-73 remains associ-
ated with the newly formed 5 end and uses its processive 5
exonuclease activity to degrade the downstream cleavage prod-
uct (DCP) (38). This activity results in liberation of the U7
snRNP from the HDE and in vivo may additionally facilitate
termination of transcription by RNA polymerase II. Cleavage
of histone pre-mRNAs likely also requires CPSF-100, a close
homologue of CPSF-73, and a protein of unknown function,
symplekin (23). Interestingly, the same three proteins are also
required for cleavage of pre-mRNAs resulting in formation of
polyadenylated mRNAs (25). This surprising finding raises the
question of how the two vastly different pre-mRNAs and their
associated processing complexes recruit the same catalytic
component to the cleavage site.
The major goal of this study was to identify new components
and interactions within the processing machinery, including the
previously proposed factor(s) that rigidifies the region of his-
tone pre-mRNA spanning from the cleavage site to the HDE
(33, 34). To achieve this goal, we used a 5 biotin-tagged
fragment of histone pre-mRNA to purify potential compo-
nents of the 3-end processing complex. We also carried out
UV-cross-linking experiments and detected previously unre-
ported interactions that occur between components of the pro-
cessing complex and the RNA substrate.
MATERIALS AND METHODS
Preparation and labeling of RNA substrates. The 86-nucleotide H2a and H1t
pre-mRNA substrates were synthesized by T7 transcription, gel purified, treated
with calf intestinal phosphatase, and labeled at the 5 end with 32P by using T4
* Corresponding author. Mailing address: Program in Molecular
Biology and Biotechnology, CB #3280, University of North Carolina,
Chapel Hill, NC 27599. Phone: (919) 843-0307. Fax: (919) 962-1274.
E-mail: dominski@med.unc.edu.
† Supplemental material for this article may be found at http://mcb
.asm.org/.
 Published ahead of print on 26 May 2009.
4045
polynucleotide kinase (16). All other RNAs were synthesized by Dharmacon
(Lafayette, CO).
In vitro processing and affinity purification of processing complexes. Nuclear
extracts were prepared from mouse myeloma cells, as described previously (16).
A typical processing reaction mixture contained 0.05 pmol of a 5-labeled RNA
substrate and the following components in the final volume of 10 l: 20 mM
EDTA (pH 8), 15 mM Tris (pH 8), 15 mM glycerol, 75 mM KCl, and 0.375 mM
dithiothreitol. The processing reaction was blocked by 100 ng of a 2O-methyl
oligonucleotide complementary to the first 15 nucleotides of the mammalian U7
snRNA (anti-mU7). A 2O-methyl oligonucleotide directed to the first 17 nu-
cleotides of the Drosophila U7 snRNA was used as a negative control (anti-dU7).
Processing samples were incubated for 90 min at 32°C, treated for 60 min with
proteinase K, and analyzed with 8%/7 M urea polyacrylamide gels. For isolation
of processing complexes, the reaction mixture was scaled up 1,000-fold and
contained 125 pmol of a 5 biotinylated RNA substrate and 1.0 mg of Saccha-
romyces cerevisiae tRNA (Invitrogen). Unless otherwise indicated, the cleavage
reaction was inhibited by adding NP-40 to give a final concentration of 0.2%.
Each sample was preincubated on ice for 10 min, transferred to 32°C for an
additional 10 min, and spun down to remove any precipitates. The supernatant
was subsequently rotated for 2 h with 50 l of streptavidin agarose beads
(Sigma). The beads were collected by gentle spinning, rinsed twice with a pro-
cessing buffer containing 0.2% NP-40, and rotated in the same buffer for 2 h.
Proteins adsorbed on the beads were recovered by boiling in a sodium dodecyl
sulfate (SDS)-containing dye, separated in an SDS-polyacrylamide gel, stained
with Coomassie blue, and analyzed by mass spectrometry (MS). A small aliquot
of the recovered proteins was additionally analyzed by Western blotting.
MS analysis. In-gel digestion with porcine trypsin (Promega) was conducted as
described previously (30). Extracted peptides were lyophilized and reconstituted
in 5 l of 50% methanol and 0.1% formic acid. Peptides were mixed 1:1 with a
saturated solution of recrystallized -cyano-4-hydroxycinnamic acid in 50% ace-
tonitrile and 0.1% trifluoroacetic acid as the matrix and analyzed by matrix-
assisted laser desorption ionization–time of flight MS using an ABI 4700 matrix-
assisted laser desorption ionization–tandem time of flight mass spectrometer
(Applied Biosystems Inc.). Mass spectra were collected automatically, and the 10
most intense peaks in the spectrum were analyzed by tandem MS (MS-MS). The
combined MS and MS-MS spectra were searched against the mouse protein
sequence database by using the MASCOT protein identification server (Matrix
Science). Only those identifications with both a significant protein score (for MS)
and a significant total ion score (for MS-MS) are reported.
Mobility shift assay. The wild-type (WT) or mutant SL RNAs were labeled at
the 5 end and used as probes in the mobility shift assay, as described previously
(13, 37). All proteins were expressed using the baculovirus expression system,
premixed with the probe in the presence of 20 mM EDTA, and analyzed by
electrophoresis with 6% native polyacrylamide gels.
UV-cross-linking and immunoprecipitation. UV-cross-linking experiments
were carried out as previously described (14). Processing reaction mixtures were
prepared in a final volume of 20 l and additionally contained 10 g of yeast
tRNA (Invitrogen). Following a 10-min incubation at 32°C, 15-l aliquots were
irradiated at room temperature with UV (1 J) while the remaining portion of
each reaction mixture was incubated for an additional 80 min to control for
processing efficiency. UV-irradiated samples were treated for 5 h with RNase T1,
boiled in an SDS-containing dye, and directly analyzed by SDS-polyacrylamide
gel electrophoresis. Immunoprecipitation experiments under native or denatur-
ing conditions were carried out as described previously (14).
Antibodies. Anti-mouse 3hExo and anti-human Lsm11 antibodies were gen-
erated in rabbits by Pacific Immunology (Ramona, CA). The anti-mouse 3hExo
antibody was directed to the C-terminal peptide of mouse 3hExo (PVEGAPA
PQMPHSRK), whereas the anti-Lsm11 antibody was generated against bacteri-
ally expressed protein consisting of the N-terminal glutathione S-transferase
followed by the first 170 amino acids of human Lsm11. The two antibodies were
affinity purified using their respective antigens. The following primary antibodies
were obtained from commercial sources: rabbit anti-human SNRPD3 (Atlas
Antibodies), mouse monoclonal anti-human Lsm10 (Bio Matrix Research), and
mouse monoclonal anti-human SmB (Sigma).
RESULTS
Affinity purification of stable processing complexes assem-
bled on histone pre-mRNA. In vitro processing of histone pre-
mRNA occurs without a detectable lag after the transfer of
reaction mixtures from 0°C to 32°C (16, 20). This high rate
makes isolating native processing complexes difficult since they
are immediately disassembled following cleavage. To reduce
the rate of the cleavage reaction, we used low concentrations of
NP-40. This mild detergent at 0.2% reduces processing in vitro
to less than 10% of the control efficiency (Fig. 1B, lane 3).
Surprisingly, a concentration of 0.1% inhibits processing more
strongly, while the lowest concentration of 0.02% shows only
modest inhibition (Fig. 1B, lanes 4 and 5).
In order to affinity purify processing complexes, we scaled up
the processing reaction mixture to 10 ml (an equivalent of
1,000 standard reaction mixtures carried out with a radioactive
substrate). Of this volume, 75% was contributed by a nuclear
extract prepared from 7.5 liters of mouse myeloma cell cul-
ture. The reaction mixture contained 2.5 g (125 pmol) of a
62-nucleotide, 5 biotinylated RNA that we refer to as the
full-length (FL) RNA (Fig. 1A). This amount of RNA resulted
in an approximately 2.5-fold-higher concentration of the sub-
strate than in a standard processing reaction mixture (Fig. 1B).
To measure the background of proteins nonspecifically asso-
ciated with the beads, we prepared a smaller mock sample
(25% volume) without the RNA substrate (Fig. 1C, lane 2).
Both samples contained 0.2% NP-40, which effectively reduces
the nonspecific background. Importantly, due to the presence
of larger-than-normal amounts of the RNA substrate, this con-
centration of detergent resulted in virtually no processing after
60 min of incubation at 32°C (see Fig. S1, lane 9, in the
supplemental material). To form and purify processing com-
plexes, the two samples were incubated at 32°C for only 10 min,
then placed on ice for an additional 10 min, and finally incu-
bated with streptavidin beads. Proteins collected on the beads
were resolved by SDS-polyacrylamide gel electrophoresis, de-
tected by staining with Coomassie blue, and identified by MS.
The mock control without RNA produced almost no back-
ground (Fig. 1C, lane 2), whereas a number of distinct protein
bands were detected in the sample containing the 5 biotinyl-
ated RNA (Fig. 1C, lane 1). Remarkably, we observed a readily
detectable amount of Lsm11, demonstrating that a significant
fraction of the RNA substrate was associated with the U7
snRNP and hence not cleaved during the incubation time. In
addition, we isolated stoichiometric amounts of the 30-kDa
SmB protein that, together with Lsm11, is part of the U7-
specific Sm ring. As expected, the FL RNA associated with
SLBP, which binds to the SL sequence upstream of the cleav-
age site. In addition to proteins specific for histone pre-RNA,
we isolated larger amounts of two general RNA binding pro-
teins: hnRNP Q and CArG box-binding factor A (CBF-A).
hnRNP Q, also known as Gry-rbp, is highly similar to hnRNP
R and exists in three different isoforms that play a role in a
number of RNA processing events, including splicing (28).
CBF-A, also known as hnRNP A/B, exists in two alternatively
spliced variants of 42 and 37 kDa and has been implicated in
various cellular processes, including regulation of transcription
on several genes (9). Finally, among the proteins associated
with the FL RNA, we identified 3hExo. We have previously
shown that 3hExo has a strong affinity to the SL sequence
at the 3 end of the mature histone mRNA but does not bind
to the same sequence located internally, as it is in the FL
RNA (13). Therefore, the affinity purification of 3hExo was
surprising.
To determine which of the identified proteins associate with
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FIG. 1. Affinity purification of a stable processing complex assembled on histone pre-mRNA. (A) Sequence of the 62-nucleotide FL RNA containing all
elements required for 3-end processing. The cleavage site is indicated with a vertical arrow, and the HDE that base pairs with the U7 snRNA is underlined. The
biotin tag is located at the 5 end of the RNA. (B) In vitro 3-end processing of a 5-labeled 86-nucleotide substrate RNA (0.05 pmol/reaction) that is nearly
identical with the RNA shown in panel A but lacks the biotin tag and contains additional nucleotides at the 5 and 3 ends. Processing was carried out with a
mouse nuclear extract (NE) under control conditions (lane 2) or in the presence of the indicated concentrations of NP-40. Lane 1 contains only the input RNA.
(C) Coomassie-stained SDS-polyacrylamide gel containing proteins of a mouse nuclear extract adsorbed on streptavidin beads in the presence of 125 pmol of
the biotinylated FL RNA (lane 1) or in its absence (lane 2). Processing complexes were formed in the presence of 0.2% NP-40 and subsequently purified on
streptavidin beads. The sample lacking the RNA was four times smaller than the RNA-containing sample. Protein identities determined by MS are shown to
the left, and size markers are to the right. In addition to FL proteins, MS identified a number of their degradation products. (D) Coomassie-stained
SDS-polyacrylamide gel containing proteins of a mouse nuclear extract that associated with the biotinylated FL RNA (125 pmol) in the absence (lane 1) or
presence (lane 2) of the anti-mU7 oligonucleotide. Protein bands present only in lane 1 are indicated with asterisks. (E) A fraction of material shown in D was
analyzed by Western blotting with anti-hnRNP Q/R (top) or mixed antibodies to 3hExo and SLBP (bottom). “NS” indicates cross-reacting proteins.
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the histone pre-mRNA in a U7-dependent manner, we re-
peated the pulldown experiment including a sample in which
the nuclear extract was preincubated with 15 nmol of anti-
mU7, a 2O-methyl oligonucleotide complementary to the first
15 nucleotides of the mammalian U7 snRNA. The anti-mU7
oligonucleotide prevents U7 snRNP from binding to the HDE
and completely blocks processing. As expected, both Lsm11
and SmB proteins were missing in the sample containing the
anti-mU7 oligonucleotide (Fig. 1D, lane 2) and they were both
readily detectable in the regular sample where the U7 snRNP
was allowed to bind to the substrate RNA (Fig. 1D, lane 1). In
addition to these two proteins, a third U7-dependent protein
was detected after the gel was restained with silver. The iden-
tity of this protein has not been determined by MS, but its size
of 15 kDa suggests that it was the SmD3 component of the of
the U7-specific Sm ring (not shown). As expected, SLBP was
found in both samples since binding of this protein to the SL is
not dependent on the U7 snRNP. Binding of hnRNP Q and
both variants of CBF-A to histone mRNA was also not affected
by the presence of the anti-mU7 oligonucleotide. This was in
contrast to what was found for 3hExo, which was detected in
stoichiometric amounts with Lsm11 and SLBP in the control
sample but was missing in the sample containing the anti-mU7
oligonucleotide. This result suggested that 3hExo, in addition
to efficiently binding to the mature histone mRNA, can also be
recruited to histone pre-mRNA in a U7-dependent manner.
The identities of SLBP, hnRNP Q, CBF-A, and 3hExo as
determined by MS were additionally confirmed by Western
blotting (Fig. 1E). All proteins, with the exception of 3hExo,
were detected using antibodies readily recognizing both mouse
and human proteins. The antibody against 3hExo was origi-
nally generated against the C-terminal peptide of the human
orthologue and only weakly cross-reacted with the mouse pro-
tein (Fig. 1E, bottom panel).
Mapping the interaction sites in histone pre-mRNA. To
determine what regions of the 62-nucleotide FL RNA interact
with the isolated proteins and to analyze the specificity of each
interaction, we used two shorter 5 biotinylated RNAs that cor-
responded to the two halves generated by the cleavage reaction:
the 31-nucleotide upstream product ending with the SL followed
by the terminal ACCCA single-stranded tail and the 31-nucleo-
tide DCP containing the HDE (Fig. 2A). In addition to the WT
DCP RNA, we used a mutant DCP version in which the purine
core of the HDE was changed from AAGA to UUCU. This
mutation abolishes binding of the U7 snRNP to the DCP (14).
Each substrate RNA (12.5 pmol) was incubated with 750 l of
a mouse nuclear extract in the presence of 0.2% NP-40 and in a
total volume of 1.0 ml (the equivalent of 100 regular reaction
mixtures), and bound proteins were analyzed by Western blotting.
To increase the sensitivity of detection of 3hExo, we generated
an antibody directed to the last 15 amino acids of the mouse
protein. The new antibody recognized a protein in a mouse nu-
clear extract of about 45 kDa, consistent with the molecular size
of the mouse 3hExo protein.
Judging by Western analysis, a relatively small fraction of the
input 3hExo protein associated with the 62-nucleotide FL
pre-mRNA (Fig. 2B, lane 2). In comparison, the SL RNA was
bound by a much larger amount of 3hExo, reflecting the high
affinity of this protein to the mature 3 end, particularly in the
presence of SLBP (Fig. 2B, lane 3). Neither the WT nor the
mutant versions of the DCP were associated with 3hExo (Fig.
2B, lanes 4 and 5). SLBP was able to bind the FL RNA and the
SL RNA (Fig. 2B, lanes 2 and 3). This is consistent with the
fact that SLBP as a component of 3-end processing machinery
binds to the 5 side of the SL structure in histone pre-mRNA
and remains associated with the same site after cleavage. Like
3hExo, SLBP did not bind to the DCP RNAs (Fig. 2B, lanes
4 and 5).
In contrast to 3hExo and SLBP, Lsm11 as a component of
U7 snRNP associated with the FL RNA and the WT DCP
RNA (Fig. 2B, lanes 2 and 4) but not with the SL RNA (lane
3). Lsm11 was also not detected on the mutant DCP RNA,
consistent with the inability of this mutant RNA to efficiently
base pair with the U7 snRNA (Fig. 2B, lane 5). hnRNP Q
associated only with the FL RNA (Fig. 2B, lane 2) and was not
isolated with either the downstream (DCP) or the upstream
(SL) cleavage products (Fig. 2B, lanes 3 and 4), suggesting that
this protein requires the cleavage site and/or its flanking se-
quences for binding. On the other hand, the two variants of
CBF-A associated only with the FL and the two DCP RNAs
(Fig. 2B, lanes 2, 4, and 5), demonstrating that the binding was
not affected by the UUCU mutation.
FIG. 2. Mapping the interaction sites in histone pre-mRNA.
(A) Sequences of biotinylated RNA halves. The U7-binding site is
underlined, and nucleotide substitutions within the purine core of the
mutant DCP RNA are indicated with lowercase letters. (B) Western
blot analysis of affinity-purified complexes assembled on 5 biotinyl-
ated RNAs (12.5 pmol), as indicated at the top of each lane. Processing
complexes were formed in the presence of 0.2% NP-40 by using RNA
substrates shown in panel A and subsequently purified on streptavidin
beads. The presence of individual proteins bound to each RNA was
detected by specific antibodies. In the top panel, anti-mouse 3hExo
and anti-SLBP antibodies were mixed. Lane 1 contains 10% of the
extract used to assemble processing complexes on each RNA species.
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Cooperative binding of 3hExo and SLBP to the SL RNA.
The above-mentioned experiment indicated that 3hExo binds
primarily to the mature 3 end of histone mRNA, but a fraction
of 3hExo is also recruited in a U7-dependent manner to pre-
mRNA prior to cleavage (see also below). Since interactions
between proteins and RNA targets that are detected in vitro
may not occur in vivo and simply result from redistribution of
cell components following cell lysis (27), we looked for evi-
dence that the binding of 3hExo to the mature histone mRNA
3 end is biologically relevant.
In vitro, 3hExo and SLBP occupy two opposing sides of the
SL structure at the 3 end of the mature histone mRNA and
each protein can bind to its target individually or simulta-
neously with the other (13, 37). One of the RNA binding
determinants for 3hExo is the single stranded ACCCA tail.
SLBP binds to the 5 side of the SL and requires two
adenosines, located 2 and 3 nucleotides upstream of the stem
(13). In addition, each protein requires specific nucleotides in
the stem and in the loop, and mutating these nucleotides re-
duces or abolishes binding (3, 13). We mutated nucleotides
critical for binding of SLBP to the SL RNA by inverting the
second GC base pair in the stem and replacing the two essen-
tial adenosines located 2 and 3 nucleotides upstream of the
stem with uridines (Fig. 3A). On the basis of our previous
analysis, these mutations were expected to selectively abolish
binding of SLBP to the SL without having a major effect on
binding of 3hExo (13). We first tested whether the resulting
mutant SL RNA can bind SLBP and hence inhibit the in vitro
processing reaction. Processing of the H1t pre-mRNA, which
requires SLBP (16), was not affected by a 2,500 molar excess
(relative to the level for the substrate RNA) of the mutant SL
RNA (Fig. 3B, lane 5). At the same time, a 10-fold-lower
concentration of the WT SL RNA was sufficient to fully inhibit
processing of this substrate (Fig. 3B, lane 3). We conclude that
the mutant SL RNA does not bind SLBP.
We next analyzed the ability of the mutant SL RNA to
compete with 5-end-labeled WT SL RNA for binding to SLBP
in the band shift assay. SLBP and 3hExo each form stable
complexes with the WT SL RNA probe that can be resolved
with a native polyacrylamide gel (13, 37). 3hExo has a larger
mass than SLBP and consistently forms a complex with the WT
SL RNA that migrates slightly more slowly than the SLBP-SL
complex (Fig. 3C, compare lanes 2 and 5). Simultaneous bind-
ing of both proteins to their respective targets on the same
molecule results in the formation of a ternary complex that
migrates more slowly than either binary complex (Fig. 3C, lane
8). Formation of the binary complex between the 5-labeled
WT SL probe and 3hExo was readily competed by a 250-fold
molar excess of either the unlabeled WT or the mutant SL
RNAs (Fig. 3C, lanes 3 and 4). Thus, the mutations in the
mutant SL RNA do not significantly affect the interaction of
the RNA with 3hExo. In contrast, the formation of the binary
complex between the 5-labeled SL RNA and SLBP was un-
affected by the mutant SL RNA (Fig. 3C, lane 7), further
demonstrating that this mutant RNA does not interact with
SLBP. The selective nature of the mutations introduced on
binding of SLBP was additionally supported by the effect of the
mutant SL competitor on the formation of the ternary com-
plex. In the presence of a high molar excess of this competitor,
the ternary complex was not formed, due to sequestration of
3hExo. As a result, the WT SL probe formed a binary complex
only with SLBP (Fig. 3C, lane 10).
To directly test the ability of the mutant SL RNA to bind
3hExo and SLBP, we labeled this RNA at the 5 end and used
it as a probe in the band shift assay (Fig. 3D). As expected from
the competition experiments, the mutant SL RNA did not
form a stable binary complex with SLBP (Fig. 3D, compare
lanes 2 and 6) while binding of 3hExo to this RNA was
unaffected (Fig. 3D, compare lanes 3 and 7). Remarkably, the
mutant SL probe formed the ternary complex containing both
SLBP and 3hExo, and the efficiency of the assembly was the
same as that for the WT SL probe (Fig. 3D, compare lanes 4
and 8). Thus, in the presence of 3hExo, the mutant SL RNA
becomes a suitable binding target for SLBP. This effect
strongly suggests that the two proteins cooperate in recogniz-
ing their respective targets on the SL RNA.
We next tested whether 3hExo can facilitate binding of a
mutant version of SLBP to the WT SL RNA. A tyrosine at
position 24 of the 73-amino-acid RNA binding domain (RBD)
of SLBP plays an important role in the recognition of the SL
RNA by SLBP (11), and replacement of this residue with an
alanine reduces the binding efficiency to 15% relative to that
of the WT protein (Fig. 3E, compare lanes 3 and 5). Impor-
tantly, the ternary complex containing 3hExo and the Y24A
SLBP mutant assembled on the WT SL probe with the same
efficiency as did the ternary complex containing WT SLBP
(Fig. 3E, compare lanes 4 and 6). Thus, 3hExo alleviates the
impaired interaction between SLBP and the SL RNA caused
by mutations within either the target RNA or SLBP itself.
As determined by the directed yeast two-hybrid system,
3hExo and SLBP do not interact unless the two proteins are
coexpressed with the SL RNA (13). We reasoned that upon
binding to the SL RNA, 3hExo undergoes structural rear-
rangements and might actively recruit SLBP to the ternary
complex by making direct protein-protein contacts that com-
pensate for the impaired interactions of SLBP with the mutant
SL RNA. To better understand the nature of this interaction
and to map regions of SLBP necessary for the interaction, we
tested various mutants of SLBP in the mobility shift assay. A
93-amino-acid portion of SLBP encompassing the 73-amino-
acid RBD and the 20 amino acids following retains the full
ability to bind WT SL RNA and to form the ternary complex
with 3hExo (Fig. 3F, lanes 4 and 6). This was expected since
the RBD is the only region of SLBP that mediates binding to
the RNA. We tested whether the 93-amino-acid region is suf-
ficient for the cooperative interaction with 3hExo by using the
mutant SL RNA, which is not recognized by SLBP as a binding
target. While the 93-amino-acid protein was unable to bind the
mutant SL RNA (Fig. 3F, lane 9), the same deletion mutant of
SLBP formed a stable ternary complex in the presence of
3hExo (lane 10). Note that in contrast to SLBP and in agree-
ment with our previous studies (37), 3hExo binds to the SL
RNA relatively weakly, as often indicated by the small amount
of the fully formed binary complex and by the presence of a
faster-migrating smear that results from the dissociation of the
complex during electrophoresis (Fig. 3D and F, compare lanes
2 and 3). Yet, 3hExo always forms a very tight and stable
ternary complex in the presence of SLBP. Thus, the cooperat-
ivity in binding the SL RNA is mutual, with each protein
stabilizing the binding of the other.
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We additionally mutated either a 9-amino-acid region of the
RBD that is not required for binding to the SL RNA (11) or
the 20-amino-acid region that follows the RBD. Both SLBP
mutants retained the ability to form a tight ternary complex
with 3hExo and the SL RNA (not shown). Thus, it is possible
that the interaction between the two proteins is mediated by
residues of SLBP that participate in RNA recognition.
U7-dependent interactions in the region between the cleav-
age site and the HDE. Studies with mutant histone pre-
mRNAs containing various insertions between the cleavage
site and the HDE suggested that this region becomes rigidified
during processing by a component of the processing machinery
and that binding of the U7 snRNP acts as a ruler to define the
cleavage site (34). To identify proteins that interact with this
FIG. 3. Cooperative binding of 3hExo and SLBP to the SL RNA. (A) Sequences of the WT SL RNA and its mutant (Mut SL), containing
nucleotide substitutions (underlined). (B) Ability of a molar excess of the WT and Mut SL RNA competitors to affect cleavage of the H1t histone
pre-mRNA by sequestering SLBP present in the nuclear extract. Each competitor was mixed with the 5-labeled H1t substrate and incubated with
a mouse nuclear extract for 1 h. The input H1t pre-mRNA is shown in lane 1. (C) Ability of a molar excess of the WT and Mut SL RNA competitors
to affect formation of binary and ternary complexes formed on the 5-labeled WT SL probe by SLBP and/or 3hExo. Each competitor was mixed
with the 5-labeled WT SL probe in the presence of 20 mM EDTA and incubated on ice for 30 min with baculovirus-expressed SLBP and/or
3hExo. Complexes were analyzed with a 6% native polyacrylamide gel. (D) Ability of the 5-end-labeled Mut SL RNA to form binary and ternary
complexes with SLBP and/or 3hExo. The Mut SL RNA probe was incubated on ice for 30 min with the baculovirus-expressed SLBP and/or 3hExo
in the presence of 20 mM EDTA, and complexes were analyzed with a 6% native polyacrylamide gel. A nonspecific complex formed by a
contaminating protein present in the SLBP preparation (lanes 2 and 6) is indicated with an asterisk. (E) Ability of 3hExo to recruit the Y24F SLBP
mutant to the WT SL RNA, giving rise to a ternary complex containing all three components (lane 6). Formation of a binary and ternary complex
containing the WT SLPB is shown for comparison in lanes 3 and 4. (F) Mapping of the region in SLBP required for the cooperative interaction
with 3hExo. The ability of the 93-amino-acid region of SLBP to form a ternary complex with 3hExo and the Mut SL probe is shown (lane 10).
Formation of a binary and ternary complex containing the WT SLPB and the 93-amino-acid SLBP mutant with the WT SL probe is shown in lanes
2 to 6.
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region, we carried out UV-cross-linking studies using a 5 la-
beled RNA that corresponds to the DCP. The 30-nucleotide
RNA begins immediately 3 of the cleavage site and, compared
to the corresponding region in the natural H2a pre-mRNA,
has the first guanosine replaced with uridine (Fig. 4A). As a
result, digestion of the DCP RNA with RNase T1 generates a
9-nucleotide labeled fragment that spans almost the entire
region between the 5 end and the HDE. In addition, a phos-
phorothioate modification was placed within the first phos-
phodiester bond (Fig. 4A) to slow down catalysis and hence to
allow UV cross-linking of transiently associated components of
the processing complex (14). In a mouse nuclear extract, the
DCP RNA is rapidly degraded to mononucleotides by the
5-to-3 exonuclease activity of CPSF-73, which depends on
binding of the U7 snRNP to the HDE (38). In parallel to the
DCP RNA, we used a related substrate containing a 2-nucle-
otide substitution within the HDE (Fig. 4A) that allowed for
an uninterrupted 15-bp duplex with the U7 snRNA and thus
more-efficient recruitment of the U7 snRNP. Both substrates,
referred to as DCP/s and DCPmax/s, respectively, were de-
graded in a mouse nuclear extract with comparable efficiencies,
and the degradation in each case was blocked by the presence
of the anti-mU7 oligonucleotide or 0.1% NP-40 (Fig. 4B, lanes
3 and 5, and data not shown).
The DCP/s and DCPmax/s RNAs were incubated with a
mouse nuclear extract for 10 min at 32°C either under regular
conditions or in the presence of the anti-mU7 oligonucleotide.
The samples were subsequently UV irradiated, digested with
an RNase T1, and analyzed with SDS gels for the presence of
cross-linked, radioactively labeled proteins. A U7-dependent
cross-link migrating at about 80 kDa was detected with both
the DCP/s and the DCPmax/s RNAs (Fig. 4C, lanes 1 and 4),
and its formation was sensitive to the presence of the anti-mU7
oligonucleotide (lanes 2 and 5) but unaffected by the presence
of the control anti-dU7 oligonucleotide (lanes 3 and 6). The
identity of this cross-linked protein was determined by immu-
noprecipitation to be CPSF-73 (Fig. 4D, lane 2). The cross-
linking efficiency of CPSF-73 was much higher with the DCP-
max/s RNA (Fig. 4C, compare lanes 1 and 4), likely reflecting
the stronger binding of the U7 snRNP to the improved HDE
and therefore more-efficient recruitment of CPSF-73 to the
RNA substrate.
Interestingly, CPSF-73 was not the only protein cross-linked
to the RNA in a U7-dependent manner. In the reaction mix-
ture containing the DCPmax/s substrate, a group of three ma-
jor U7-dependent cross-links and two minor cross-links were
evident (Fig. 4C, lanes 4 and 6). The same major cross-links
were also detected with the DCP/s substrate, although they
were much less intense and visible only after longer exposure
times (not shown). Since each radioactively labeled protein was
covalently linked to a 9-nucleotide RNA fragment that corre-
sponds to a mass of about 3 kDa, the approximate molecular
masses of the major cross-linked proteins were estimated at 28
to 29 kDa, 16 to 17 kDa, and 14 to 15 kDa.
To determine whether cross-linking of the three major pro-
teins depends on the ongoing cleavage reaction in the same
fashion as does cross-linking of CPSF-73, we repeated the
experiment in the presence of NP-40. Addition of this deter-
gent to 0.1% almost completely blocks recruitment of CPSF-73
to the substrate (Fig. 4C, lane 8) and inhibits degradation of
the DCP (Fig. 4B, lane 5), although it has no effect on binding
of the U7 snRNP to the HDE (Fig. 2B, lane 4). Significantly,
the presence of 0.1% NP-40, while inhibiting the degradation,
greatly enhanced the intensity of all three major cross-links
(Fig. 4C, lane 8), and their formation remained sensitive to the
presence of the anti-mU7 oligonucleotide (lane 9).
Identification of U7-dependent cross-links. The sizes of the
novel U7-dependent cross-linked proteins, ranging from ap-
FIG. 4. U7-dependent interactions in the region between the cleav-
age site and the HDE. (A) Sequence of the DCP/s and DCPmax/s
substrates containing a single radioactive phosphate at the 5 end
(asterisk) and a phosphorothioate modification (s) between nucleo-
tides 1 and 2. The HDE is underlined, and the site recognized by
RNase T1 is indicated with an arrowhead. Nucleotide substitutions
within the HDE of the DCPmax/s RNA that improve the base pair
interaction with the U7 snRNA are indicated with lowercase letters.
(B) In vitro degradation of the DCPmax/s RNA. Samples were incu-
bated for 90 min at 32°C either under control conditions (lane 2) or in
the presence of the indicated reagents (lanes 3 to 5). The length of the
RNA substrate and the position of labeled mononucleotide are indi-
cated to the left. (C) UV-cross-linking using the DCP/s (lanes 1 to 3)
and DCPmax/s (lanes 4 to 9) RNAs. Samples were preincubated for 10
min at 32°C either under control conditions or in the presence of the
indicated oligonucleotides. Samples in lanes 8 and 9 additionally con-
tained 0.1% NP-40. Following incubation, samples were UV irradi-
ated, treated with RNase T1, and separated in an SDS-polyacrylamide
gel. The 80-kDa cross-link at the top of the gel is indicated with the
large arrow. Low-molecular-weight U7-dependent cross-links are in-
dicated with question marks (more-intense bands) and arrows (less-
intense bands). (D) Immunoprecipitation (IP) of the 80-kDa cross-
linked protein with anti-CPSF-73 antibody. A processing reaction
mixture containing the 5-labeled DCPmax/s substrate was UV-irradi-
ated, treated with RNase T1, denatured by boiling in the presence of
SDS, and incubated with the anti-CPSF-73 antibody (lane 2) or the
anti-CBF-A antibody (lane 3). Precipitated proteins were resolved in
an SDS-polyacrylamide gel and detected by autoradiography. The in-
put (20%) is shown in lane 1.
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proximately 15 to 30 kDa, and their interaction with the DCP
in the presence of NP-40 suggested that these proteins may be
components of the U7-specifc Sm ring. The 30 kDa cross-
linked protein is likely SmB, which is the largest of the com-
mon Sm proteins associated with the U7 snRNA and was
readily detected by MS in processing complexes assembled in
the presence of NP-40 on the FL RNA (Fig. 1C and D). The
fastest-migrating protein may in turn be Lsm10, while the pro-
tein of intermediate mobility is likely SmD3. The two minor
cross-links migrating slightly over 20 kDa are likely degrada-
tion products of the SmB protein.
To determine the identities of the cross-linked proteins, we
carried out immunoprecipitation experiments using antibodies
specific to individual components of the U7-specific ring. A
monoclonal antibody against SmD3 recognizes a major band at
approximately 15 kDa by Western blot analysis, in agreement
with the molecular mass of SmD3 (Fig. 5A, lane 1). As deter-
mined by the immunoprecipitation/Western assay, the anti-
body is not suitable for immunoprecipitation under native con-
ditions (Fig. 5A, lane 2) but precipitates the SmD3 antigen
with a low efficiency under denaturing conditions containing
SDS (lane 3). Importantly, the presence of SDS has the ad-
vantage over the native conditions, as it completely disrupts the
U7 Sm ring, thus allowing immunoprecipitation of the SmD3
protein alone rather than as a part of the entire complex. The
antibody against SmD3 selectively precipitated the expected
cross-linked protein (Fig. 5B, lanes 4 and 6, and C, lanes 5 and
9), and the amount of the precipitated material was consistent
with the low efficiency of SmD3 precipitation (Fig. 5A, lane 3).
An antibody directed against SLBP did not precipitate any
radioactive protein (Fig. 5B, lanes 5 and 7), confirming the
specificity of the anti-SmD3 precipitation. On the basis of these
results, we conclude that the U7-dependent cross-linked pro-
tein migrating at 16 to 17 kDa is SmD3.
By Western analysis, a monoclonal antibody against SmB
recognizes a protein that migrates at about 28 kDa (not
shown). This is consistent with the molecular mass of SmB and
the position of this protein in Coomassie-stained gels contain-
ing components of the processing machinery (Fig. 1C and D).
Under denaturing conditions, the same antibody selectively
precipitated the largest cross-linked protein, thus confirming
its identity as SmB (Fig. 5C, lanes 4 and 8). An antibody
against 3hExo used as a negative control did not precipitate
any protein (Fig. 5C, lanes 6 and 10). To determine the iden-
tities of the smallest of the cross-linked proteins predicted to
be Lsm10, we used an anti-Lsm10 monoclonal antibody. This
antibody does not detect the endogenous protein on Western
blots but was successfully used for detection of U7 snRNP and
histone locus bodies in human cells by immunofluorescence
(19). Under both native conditions (not shown) and denaturing
conditions, the anti-Lsm10 antibody did not precipitate any
radioactive protein (Fig. 5C, lanes 3 and 7).
We next investigated whether the smallest cross-linked pro-
tein is a component of the U7-snRNP by using the Y12 anti-Sm
monoclonal antibody, which recognizes symmetrical dimethyl-
arginines in Sm proteins (5) and under native conditions pre-
cipitates entire snRNPs. Under these conditions, the Y12 an-
tibody precipitated all proteins cross-linked to the DCPmax/s
substrate in a U7-dependent manner, including the minor pu-
tative SmB degradation products, although it failed to precip-
itate other proteins that associated with the same substrate
independently of the U7 snRNP (Fig. 5D, lane 3). We con-
clude that the smallest cross-linked protein is a component of
the U7 snRNP and, on the basis of its size, is likely Lsm10,
which migrates immediately below SmD3 (32).
U7-dependent interaction in the SL region. An intriguing
observation from the above-mentioned cross-linking studies is
that while the DCP RNA makes close contacts with SmD3,
SmB, and Lsm10, we never detected a cross-link that would be
consistent with the size of Lsm11. One possibility is that Lsm10
interacts with the region located immediately 3 of the cleavage
site that is present in the DCP RNA but that Lsm11 binds
nucleotides 5 of the cleavage site that are missing in the DCP
RNA. We previously used a site-specifically labeled FL RNA
FIG. 5. Identification of U7-dependent cross-links. (A) Immuno-
precipitation (IP) of SmD3 from a mouse nuclear extract by a specific
anti-SmD3 mouse monoclonal antibody under native (lane 2) or de-
naturing (lane 3) conditions. Lane 1 contains 20% of the extract used
for each immunoprecipitation. (B) Immunoprecipitation of cross-
linked proteins by the anti-SmD3 antibody. A processing reaction
mixture containing the 5-labeled DCPmax/s substrate was UV irradi-
ated, treated with RNase T1, denatured by boiling in the presence of
SDS, and incubated with the anti-SmD3 (lanes 4 and 6) or anti-SLBP
(lanes 5 and 7) antibody. Precipitated proteins were resolved in an
SDS-polyacrylamide gel and detected by autoradiography. The input
(20%) is shown in lane 1. An image of the boxed gel fragment observed
after a longer exposure time (lanes 4 and 5) is shown to the right.
Cross-links formed in the presence of the anti-dU7 and the anti-mU7
oligonucleotides are shown in lanes 2 and 3, respectively. (C) Immu-
noprecipitation of cross-linked proteins by antibodies indicated at the
top of each lane. The experiment was carried out as described for
panel B. The input (20%) is shown in lane 1. An image of the boxed
gel fragment observed after a longer exposure time (lanes 3 to 6) is
shown to the right. Cross-links formed in the presence of the anti-mU7
oligonucleotide are shown in lane 2. (D) Immunoprecipitation of
cross-linked proteins by the anti-Sm Y12 monoclonal antibody under
native conditions. A monoclonal antibody against CstF-77 was used as
a negative control (lane 2). The input (20%) is shown in lane 1.
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substrate (FL/5s) that contained a single radioactive phosphate
between the two last nucleotides of the stem and five phos-
phorothioate modifications in the region flanking the cleavage
site (14). Interestingly, with this substrate, we observed the
formation of a U7-dependent cross-link that migrated slightly
more slowly than the cross-link formed with SLBP (14), a
mobility consistent with the size of 3hExo or Lsm11 (Fig. 1C
and D).
To characterize this cross-link in more detail and to deter-
mine whether it was formed with 3hExo or Lsm11, we used a
similar substrate that lacked a guanosine upstream of the SL
and contained a radioactive label at the 5 end (Fig. 6A). After
90 min of incubation at 32°C, the labeled FL/5s RNA was
processed with an efficiency of 60% (Fig. 6B, lane 1). This
efficiency is significantly lower than the typical 95% observed
with substrates lacking phosphorothioate modifications near
the cleavage site (Fig. 1B, lane 2). Due to the presence of
phosphorothioate modifications, the FL/5s pre-mRNA was ad-
ditionally cleaved at a minor site 4 nucleotides past the stem.
Processing of the FL/5s pre-mRNA responded to various RNA
competitors in the same fashion as did the regular substrate,
with the anti-mU7 preventing any cleavage (Fig. 6B, lane 2).
The WT SL RNA competitor at a 250-fold molar excess re-
duced processing of the FL/5s pre-mRNA to 40% (Fig. 6B,
FIG. 6. U7-dependent interaction in the SL region. (A) Sequence of the FL/5s substrate. The 32P radioactive label at the 5 end is represented
by an asterisk, and the major and minor cleavage sites are indicated with large and small arrows, respectively. The site recognized by RNase T1
is indicated with an arrowhead, and phosphorothioate bonds are represented by “s.” (B) In vitro 3-end processing of the FL/5s substrate labeled
at the 5 end. Samples were incubated for 90 min at 32°C under control conditions (lanes 1 and 6) or in the presence of a molar excess of the
indicated competitors (lanes 2 to 5 and 7 to 10). Samples in lanes 6 to 10 additionally contained 0.1% NP-40. Note that the first lane containing
the probe alone is not numbered, so the remaining lanes have the same numbers as the corresponding lanes in panel C. Products generated by
cleavage at the major and minor cleavage sites are indicated with large and small arrows, respectively. (C) UV-cross-linking with the FL/5s
substrate labeled at the 5 end. A fraction of each sample shown in panel B, following 10 min of incubation at 32°C, was UV irradiated, treated
with RNase T1, and separated in an SDS-polyacrylamide gel. The unknown cross-link is indicated with a question mark. (D) Hypothetical model
depicting possible interactions in the stable processing complex assembled on histone pre-mRNA before cleavage. The top (gray) and bottom
(black) lines represent histone pre-mRNA and U7 snRNA, respectively. Interactions detected by UV cross-linking are represented by asterisks.
The site of cleavage by CPSF-73 is indicated. 3hExo is actively recruited to the SL structure by the U7 snRNP and possibly by SLBP. After
cleavage, 3hExo tightly associates with the mature 3 end bound by SLBP.
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lane 4). This is consistent with the fact that all derivatives of the
H2a pre-mRNAs are only partially dependent on SLBP (16).
The mutant SL RNA, which is unable to bind SLBP while
retaining the ability to bind 3hExo (Fig. 3), had no effect on
the processing of this substrate (Fig. 6B, lane 5). This result
further supports our initial observation (Fig. 3B) that 3hExo is
not required for 3-end processing in vitro. We prepared the
same set of reaction mixtures with 0.1% NP-40, which com-
pletely abolished processing of the FL/5s substrate (Fig. 6B,
lanes 6 to 10).
After a 10-min incubation at 32°C, an aliquot of each pro-
cessing reaction mixture shown in Fig. 6B was UV irradiated,
treated with RNase T1, and analyzed with an SDS-polyacryl-
amide gel for the presence of radioactively labeled cross-linked
proteins. RNase T1 degraded the FL/5s RNA to a radioactive
fragment containing the entire SL and extending 3 nucleotides
past the cleavage site (Fig. 6A). Note that guanosines within
the double-stranded stem are not recognized by the enzyme.
Under regular reaction conditions, the 10-min incubation time
was sufficient to process about 40% of the input RNA (see Fig.
S2A in the supplemental material). After this time, strong
cross-links were formed with SLBP and its slightly smaller
degradation product (Fig. 6C, lane 1). The identity of these
cross-links was confirmed by immunoprecipitation with an
anti-SLBP antibody (not shown) (14). As expected, the two
SLBP cross-links were competed off by a 250-fold molar excess
of the WT SL RNA (Fig. 6C, lane 4) and remained unaffected
by the presence of the anti-mU7 oligonucleotide (Fig. 6C, lane
2). In addition, we observed the formation of another cross-
link, which migrated at 55 kDa, slightly above the SLBP
cross-link, a mobility that was consistent with the size of either
Lsm11 or 3hExo. Formation of this previously unidentified
cross-link was prevented by the anti-mU7 oligonucleotide and
by a 250-fold molar excess of the WT SL RNA competitor (Fig.
6C, lanes 2 and 4, respectively). This behavior suggested that
the 55-kDa cross-link is 3hExo and results from the postcleav-
age binding of the protein to the upstream product terminating
with the SL. Since the antibody against 3hExo was not active
in immunoprecipitations (not shown), we tested the identity of
the 55 kDa cross-link by using the mutant SL RNA, which
selectively binds 3hExo. This RNA competitor had no effect
on the processing reaction (Fig. 6B, lane 5) or the formation of
the two SLBP cross-links but nearly completely eliminated the
55-kDa cross-link (Fig. 6C, lane 5), strongly suggesting that it
indeed is 3hExo.
Interestingly, in the presence of 0.1% of NP-40, we still
detected the 55 kDa cross-link, and its formation was pre-
vented by the anti-mU7 oligonucleotide (Fig. 6C, lanes 6 and
7). Note that there is no detectable processing of the FL/5s
substrate after 90 min of incubation in the presence of 0.1%
NP-40 (Fig. 6B, compare lanes 6 and 7; see also Fig. S2B in the
supplemental material) and that samples were UV irradiated
after 10 min of incubation. This result indicates that 3hExo is
actively recruited to histone pre-mRNA prior to cleavage in a
manner dependent on the U7 snRNP, thus confirming our
initial observations from the affinity purification experiments.
In addition, the lack of any cross-link consistent with the size of
Lsm11 suggests that this component of the U7-specific Sm
ring, in contrast to Lsm10, SmB, and SmD3, does not contact
the RNA substrate during 3-end processing.
DISCUSSION
As a result of studies of both yeast and mammalian cells, the
mechanism of 3-end processing by cleavage/polyadenylation is
relatively well understood (8, 40). The macromolecular assem-
bly catalyzing this process is conserved throughout eukaryotes
and consists of at least 12 protein components that form a
complex network of interactions with each other and sequence
elements in the pre-mRNA (25). Metazoan histone pre-
mRNAs are cleaved at the 3 end by a distinct process for
which many details remain unknown. So far, only five factors
have been identified through both biochemical and genetic
studies (12), and two of them are common with cleavage/
polyadenylation: CPSF-73, which functions as the 3 endonu-
clease (14, 26), and symplekin, which plays a yet uncharacter-
ized role in both processing reactions (23). The three
remaining factors include SLBP, which binds the SL structure
upstream of the cleavage site; the U7 snRNP, which interacts
with the HDE downstream of the cleavage site; and ZFP100,
which is believed to bridge the two flanking factors. The two
processing reactions likely also share CPSF-100, which physi-
cally interacts with CPSF-73 (15) and may function as a regu-
latory subunit of this endonuclease (24). This list is almost
certainly incomplete, and further studies are required both for
identification of new processing factors and for determination
of how they interact with each other within the processing
complex to carry out the endonucleolytic cleavage. In this
study, we analyzed the composition of a stable processing com-
plex assembled on histone pre-mRNA in the presence of low
concentrations of NP-40 that inhibit the cleavage reaction. We
also used UV-cross-linking to detect and characterize previ-
ously undescribed interactions within the processing complex.
Histone pre-mRNA stably associates with known processing
factors. Among the proteins identified by MS as components
of a stable, catalytically inactive complex were known process-
ing factors (SLBP and two proteins of the U7 snRNP, Lsm11
and SmB). In addition, silver staining detected a protein with
a molecular size consistent with the third protein of the U7
snRNP (SmD3), although its identity has not been confirmed
by MS. Most notable was the absence of other factors that are
known or believed to function in 3-end processing of histone
pre-mRNAs (CPSF-73, CPSF-100, symplekin, and ZFP100).
Association of these proteins with the histone pre-mRNA may
be sensitive to the presence of NP-40, transient in nature,
and/or substoichiometric in comparison to what was found for
the most abundant and stable components (SLBP and the U7
snRNP).
In addition to processing-specific proteins, we isolated larger
amounts of hnRNP Q (28) and CBF-A (9), two multifunctional
and abundant proteins involved in various aspects of RNA and
DNA metabolism. hnRNP Q seems to interact near the cleav-
age site, whereas CBF-A binds to the DCP, and this interaction
is not abolished by mutating the AAGA purine core. We also
isolated smaller amounts of a third general RNA binding pro-
tein, hnRNP A1 (Fig. 1C). Our attempts to sufficiently deplete
these proteins from mouse nuclear extracts by specific antibod-
ies were unsuccessful, so the importance of these proteins for
3-end processing of histone pre-mRNAs remains to be deter-
mined. However, we favor the possibility that binding of all
three hnRNPs to histone pre-mRNAs is not biologically rele-
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vant (or at most plays only an auxiliary role) and simply results
from using an excess of the substrate in the pulldown experi-
ments.
Role for 3hExo in histone mRNA metabolism? The most
intriguing result of the affinity purification experiments was the
isolation of 3hExo. The association of 3hExo is primarily a
postprocessing event resulting from a very strong affinity of this
protein to the mature 3 end of histone mRNA. An important
role in binding 3hExo to the cleaved histone mRNA is played
by the cooperation in binding between SLBP and 3hExo. The
cooperation is mutual, with 3hExo allowing SLBP to bind a
mutant version of the SL RNA and vice versa, with SLBP
stabilizing the relatively weak interaction of 3hExo with the
SL RNA. Since 3hExo and SLBP do not interact in the ab-
sence of the SL RNA (13), the most likely mechanism of the
cooperative binding involves a direct protein-protein interac-
tion triggered by the association of each protein with its re-
spective RNA site. By using various mutants of SLBP, we
narrowed down the region of SLBP involved in this interaction
to the RBD.
Interestingly, both affinity purification and cross-linking ex-
periments suggest that 3hExo is recruited to the processing
complex in a U7-dependent manner prior to cleavage of his-
tone pre-mRNA. The observation that 3hExo can be seques-
tered from nuclear extracts by the mutant SL RNA without
causing any reduction in the efficiency of cleavage indicates,
however, that 3hExo is not an essential processing factor. An
attractive possibility is that 3hExo is initially actively recruited
to the histone pre-mRNA and following cleavage is rapidly
transferred to the mature 3 end, to which it has a strong
affinity. The mechanism by which 3hExo is recruited to his-
tone pre-mRNA is unknown. One possibility is that the base
pairing between the U7 snRNA and the HDE promotes struc-
tural changes in histone pre-mRNA (21) that stimulate an
interaction of 3hExo with the internally located SL. Alterna-
tively, 3hExo may be stabilized on the SL in histone pre-
mRNA by interactions with a component of the U7 snRNP
and SLBP.
In mammalian cells, 3hExo has been detected in the cyto-
plasm, the nucleoplasm, and the nucleolus (37), likely perform-
ing a plethora of tasks in these compartments, including 3-end
trimming of the 5.8S rRNA in the nucleolus (1, 17). More
recently, 3hExo has been also shown to localize to promyelo-
cytic leukemia (PML) bodies (19). The function of PML bodies
is unclear, although they have been implicated in many distinct
processes, including cell stress response, cycle regulation,
DNA repair, and transcription (7). Interestingly, in S phase,
PML bodies double and become more dynamic, suggesting a
role in monitoring chromatin integrity during DNA replication
(10), a function closely related to histone mRNA metabolism.
PML bodies often communicate with Cajal bodies (35). A
subset of Cajal bodies, which harbor factors involved in pro-
cessing of histone pre-mRNAs, are found close to histone loci
(18, 19). We believe that the localization data, together with
the active recruitment of 3hExo to the processing complex and
the cooperation with SLBP in binding to the mature histone
mRNA 3 end, support the notion that 3hExo has a biological
relevance to in vivo histone mRNA biogenesis and/or metab-
olism. Interestingly, the cytoplasmic histone mRNAs typically
contain three nucleotides after the SL (29), while cleavage
occurs five nucleotides past the SL, indicating that the last two
nucleotides are removed during the transition from the nucleus
to the cytoplasm. This trimming resembles a similar reaction in
vitro, with recombinant SLBP and 3hExo bound to the SL
(13), and further suggests that these two proteins also bind the
mature 3 end of histone mRNA in vivo.
One obvious potential role for 3hExo, an active 3 exonu-
clease, was in the rapid degradation of histone mRNAs that
occurs at the end of S phase or after arrest of DNA replication.
However, recent data indicate that the degradation of histone
mRNAs under each circumstance is mediated by other pro-
teins (29). Thus, how 3hExo functions in histone mRNA me-
tabolism remains to be elucidated.
The region upstream of the HDE interacts with proteins of
the U7-specific Sm ring. Cross-linking experiments revealed
that the region located between the cleavage site and the HDE
interacts in a U7-dependent manner with a set of three pro-
teins, ranging in size from approximately 15 to 30 kDa. The
identities of two cross-linked proteins were determined by im-
munoprecipitation as SmB and SmD3. On the basis of the
electrophoretic mobility, the smallest of the three proteins is
likely Lsm10. This interpretation is further supported by the
predicted position of Lsm10 in the U7-specific ring. As dem-
onstrated by structural studies of the conventional Sm ring, the
SmD1 protein occupies the position adjacent to SmB (22).
Since, in the U7-specific ring, Lsm10 substitutes for SmD1, it
can be assumed that Lsm10, together with SmD3 and SmB,
forms a continuous platform that tightly associates with the
pre-mRNA region spanning from the cleavage site to the
HDE. Importantly, this configuration would place Lsm10 close
to the cleavage site, potentially explaining the mechanism of
the U7-dependent molecular ruler that functions during 3-end
processing to determine the cleavage site in histone pre-
mRNA (33, 34). Histone pre-mRNA is likely to bind to the top
surface of the U7-specific Sm ring. The existence of a second-
ary RNA binding site in this part of the ring, in addition to the
known binding site in the internal cavity, was shown for a
hexamer of the Pyrococcus abyssi Sm1 protein in a complex
with RNA (36).
Mechanistically, binding of the Sm ring to the region up-
stream of the HDE may help in stabilizing the U7 snRNP on
the pre-mRNA substrate. A similar role is played by the SmD3,
SmB, and SmD1 proteins of the U1 snRNP during pre-mRNA
splicing (39). These proteins, through their positively charged
C-terminal regions, interact with nucleotides in the vicinity of
the 5 splice, thus allowing more-stable association of the U1
snRNP with intron-containing pre-mRNAs. In addition to sta-
bilizing the U7 snRNP, the three proteins may also rigidify the
region upstream of the HDE or appropriately expose the
cleavage site. The former function was previously postulated
for an unknown component of the processing machinery, per-
haps a protein of the U7 snRNP (33) or symplekin (23).
We recently showed that truncated DCP substrates contain-
ing 7 or fewer nucleotides upstream of the HDE instead of the
typical number of 9 to 11 nucleotides (4) are not degraded by
the 5 exonuclease activity of CPSF-73, although they bind the
U7 snRNP with normal efficiency (38). Presumably, the trun-
cated DCP substrates contain insufficient space 5 of the HDE
to bind the Sm ring of the U7 snRNP and therefore to recruit
(or activate) CPSF-73.
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Surprisingly, in spite of testing a variety of specifically la-
beled histone pre-mRNAs and conditions, we were unable to
detect a cross-link that might correspond to Lsm11. We con-
clude that this component of the Sm ring, in contrast to the
three other Sm proteins, is unlikely to tightly contact the sub-
strate and probably plays a more specific role in processing,
possibly directly or indirectly recruiting CPSF-73 to histone
pre-mRNA.
A model depicting the predicted interactions between Sm
proteins and histone pre-mRNA during 3-end processing and
the proposed configuration of the Sm ring in relation to the
substrate and the cleavage site is shown in Fig. 6D. In this
model, the cleavage site is flanked by Lsm10 and Lsm11, the
two unique components of the U7-specifc Sm core that are
essential for processing (31). The interactions with the three
components of the Sm complex that occur downstream of the
cleavage site (Lsm10, SmD3, and SmB) are perfectly suited to
serve as a molecular ruler to determine the site of the endo-
nucleolytic attack by CPSF-73, which is located at a fixed dis-
tance from the HDE (33, 34).
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